BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • Coronavirus
    • IVDs on the rise
    • Artificial intelligence
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, November 20, 2024
BioWorldBioWorld MedTechBioWorld AsiaBioWorld Science

BioWorld

  • Cholesterol plaque in artery

    Newamsterdam’s obicetrapib combo nails phase III LDL-C endpoints

    “It all comes down to outcomes,” said Michael Davidson, CEO of Newamsterdam Pharma Co. NV, which hailed “robust” and “consistent” data from its phase III study testing a...
More in BioWorld

BioWorld MedTech

  • Female hands holding heart on cardiogram

    New diagnostics, trials address deadly disparities in women’s cardiac care

    While women with “big hearts” play well in popular culture, cardiologists see a very different picture – with significant implications for women’s health and medical care....
More in BioWorld MedTech

BioWorld Science

  • Woman holding stomach with inflammation

    Holistic strategies needed to diagnose and treat endometriosis

    Endometriosis has been woefully under-recognized in the medical community, and consequently, the delay between onset and diagnosis is often quite long, with some women...
More in BioWorld Science

BioWorld Asia

  • Concept of business partnership

    Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

    Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth...
More in BioWorld Asia

BioWorld Insider Podcast

Play buttonIn the newest BioWorld Insider podcast, Ranjit Bindra, founder of Modifi Biosciences Inc., talks about how his company got creative on the rocky road to a multibillion-dollar buyout.
Listen now
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing